blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1567014

EP1567014 - RAPID ONE-STEP METHOD FOR GENERATION OF ANTIGEN LOADED DENDRITIC CELL VACCINE FROM PRECURSORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.08.2012
Database last updated on 26.06.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU
published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Baylor Research Institute
Suite 125, 3434 Live Oak Street
Dallas, TX 75204 / US
[2005/35]
Inventor(s)01 / BANCHEREAU, Jacques, F.
6730 Northhaven Road
Dallas, TX 75230 / US
02 / PALUCKA, Anna K.
3000 Blackburn St., 2522
Dallas, TX 75402 / US
 [2011/39]
Former [2005/35]01 / BANCHEREAU, Jacques, F.
6730 Northhaven Road
Dallas, TX 75230 / US
02 / PALUCKA, Anna K.
101 North Brookside Drive Apartment 106
Dallas, TX 75214 / US
Representative(s)Weber, Martin, et al
Uexküll & Stolberg Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstrasse 4
22607 Hamburg / DE
[N/P]
Former [2009/51]Weber, Martin, et al
Uexküll & Stolberg Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Former [2005/35]Weber-Quitzau, Martin, et al
Beselerstrasse 4
D-22607 Hamburg / DE
Application number, filing date03808435.604.12.2003
[2005/35]
WO2003US38553
Priority number, dateUS20020430791P04.12.2002         Original published format: US 430791 P
[2005/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004050855
Date:17.06.2004
Language:EN
[2004/25]
Type: A2 Application without search report 
No.:EP1567014
Date:31.08.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 17.06.2004 takes the place of the publication of the European patent application.
[2005/35]
Type: B1 Patent specification 
No.:EP1567014
Date:28.09.2011
Language:EN
[2011/39]
Search report(s)International search report - published on:US03.02.2005
(Supplementary) European search report - dispatched on:EP16.12.2005
ClassificationIPC:A01N63/00, A61K45/00, A61K47/00, C12N5/00, C12N5/02, C12N5/0784
[2011/39]
CPC:
C12N5/0639 (EP,US); A61K39/0011 (US); A61K39/4615 (EP);
A61K39/4622 (EP); A61K39/4637 (EP); A61K39/4644 (EP);
A61K39/464456 (EP); A61K39/464486 (EP); A61K39/464491 (EP);
A61K39/464492 (EP); A61P35/00 (EP); A61P37/04 (EP);
A61P43/00 (EP); A61K2039/5152 (US); A61K2039/5154 (US);
A61K2239/57 (EP); C12N2501/22 (EP,US); C12N2501/25 (EP,US) (-)
Former IPC [2005/35]A01N63/00, A61K45/00, A61K47/00, C12N5/00, C12N5/02, C12N5/06
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/35]
TitleGerman:EINSTUFIGES SCHNELLVERFAHREN ZURHERSTELLUNG EINES ANTIGENBELADENEN DENDRITENZELLIMPFSTOFFS AUS VORSTUFEN[2005/35]
English:RAPID ONE-STEP METHOD FOR GENERATION OF ANTIGEN LOADED DENDRITIC CELL VACCINE FROM PRECURSORS[2005/35]
French:PROCEDE RAPIDE DE PRODUCTION EN UNE ETAPE D'UN VACCIN A BASE DE CELLULES DENDRITIQUES CHARGEES EN ANTIGENE A PARTIR DE PRECURSEURS[2011/37]
Former [2005/35]PROCEDE RAPIDE DE PRODUCTION EN UNE ETAPE D'UN VACCIN CELLULAIRE DENDRITIQUE CHARGE EN ANTIGENE A PARTIR DE PRECURSEURS
Entry into regional phase09.06.2005National basic fee paid 
09.06.2005Search fee paid 
09.06.2005Designation fee(s) paid 
09.06.2005Examination fee paid 
Examination procedure09.06.2005Examination requested  [2005/35]
05.04.2006Despatch of a communication from the examining division (Time limit: M06)
09.10.2006Reply to a communication from the examining division
21.09.2007Despatch of a communication from the examining division (Time limit: M06)
20.03.2008Reply to a communication from the examining division
07.05.2008Despatch of a communication from the examining division (Time limit: M04)
18.08.2008Reply to a communication from the examining division
07.09.2009Cancellation of oral proceeding that was planned for 16.09.2009
16.09.2009Date of oral proceedings
16.09.2009Date of oral proceedings (cancelled)
23.12.2010Communication of intention to grant the patent
14.04.2011Fee for grant paid
14.04.2011Fee for publishing/printing paid
Divisional application(s)EP10011505.4  / EP2301356
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.04.2006
Opposition(s)29.06.2012No opposition filed within time limit [2012/36]
Fees paidRenewal fee
20.12.2005Renewal fee patent year 03
19.12.2006Renewal fee patent year 04
12.12.2007Renewal fee patent year 05
15.12.2008Renewal fee patent year 06
11.12.2009Renewal fee patent year 07
15.12.2010Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
DK28.09.2011
EE28.09.2011
FI28.09.2011
HU28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
TR28.09.2011
IE04.12.2011
LU04.12.2011
BG28.12.2011
GB28.12.2011
GR29.12.2011
CH31.12.2011
LI31.12.2011
MC31.12.2011
FR02.01.2012
ES08.01.2012
PT30.01.2012
[2013/45]
Former [2013/44]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
DK28.09.2011
EE28.09.2011
FI28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
TR28.09.2011
IE04.12.2011
LU04.12.2011
BG28.12.2011
GB28.12.2011
GR29.12.2011
CH31.12.2011
LI31.12.2011
MC31.12.2011
FR02.01.2012
ES08.01.2012
PT30.01.2012
Former [2013/29]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
DK28.09.2011
EE28.09.2011
FI28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
IE04.12.2011
LU04.12.2011
BG28.12.2011
GB28.12.2011
GR29.12.2011
CH31.12.2011
LI31.12.2011
MC31.12.2011
FR02.01.2012
ES08.01.2012
PT30.01.2012
Former [2013/25]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
DK28.09.2011
EE28.09.2011
FI28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
IE04.12.2011
LU04.12.2011
GB28.12.2011
GR29.12.2011
CH31.12.2011
LI31.12.2011
MC31.12.2011
FR02.01.2012
ES08.01.2012
PT30.01.2012
Former [2013/22]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
DK28.09.2011
EE28.09.2011
FI28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
IE04.12.2011
GB28.12.2011
GR29.12.2011
CH31.12.2011
LI31.12.2011
MC31.12.2011
FR02.01.2012
ES08.01.2012
PT30.01.2012
Former [2013/19]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
DK28.09.2011
EE28.09.2011
FI28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
IE04.12.2011
GB28.12.2011
GR29.12.2011
CH31.12.2011
LI31.12.2011
MC31.12.2011
FR02.01.2012
PT30.01.2012
Former [2012/49]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
DK28.09.2011
EE28.09.2011
FI28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
IE04.12.2011
GB28.12.2011
GR29.12.2011
CH31.12.2011
LI31.12.2011
MC31.12.2011
PT30.01.2012
Former [2012/47]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
DK28.09.2011
EE28.09.2011
FI28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
IE04.12.2011
GB28.12.2011
GR29.12.2011
MC31.12.2011
PT30.01.2012
Former [2012/46]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
DK28.09.2011
EE28.09.2011
FI28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
GB28.12.2011
GR29.12.2011
MC31.12.2011
PT30.01.2012
Former [2012/35]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
DK28.09.2011
EE28.09.2011
FI28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
GR29.12.2011
MC31.12.2011
PT30.01.2012
Former [2012/33]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
EE28.09.2011
FI28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
GR29.12.2011
MC31.12.2011
PT30.01.2012
Former [2012/23]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
EE28.09.2011
FI28.09.2011
IT28.09.2011
NL28.09.2011
RO28.09.2011
SE28.09.2011
SI28.09.2011
SK28.09.2011
GR29.12.2011
PT30.01.2012
Former [2012/21]AT28.09.2011
BE28.09.2011
CY28.09.2011
CZ28.09.2011
FI28.09.2011
SE28.09.2011
SI28.09.2011
GR29.12.2011
Former [2012/18]AT28.09.2011
BE28.09.2011
CY28.09.2011
FI28.09.2011
SE28.09.2011
SI28.09.2011
GR29.12.2011
Former [2012/12]AT28.09.2011
CY28.09.2011
FI28.09.2011
SE28.09.2011
SI28.09.2011
GR29.12.2011
Former [2012/11]AT28.09.2011
FI28.09.2011
SE28.09.2011
SI28.09.2011
GR29.12.2011
Former [2012/10]FI28.09.2011
SE28.09.2011
GR29.12.2011
Former [2012/09]FI28.09.2011
Documents cited:Search[AD]US6004807  (BANCHEREAU JACQUES [FR], et al) [AD] 21 * column 6, line 47 - line 57 *;
 [X]WO0121653  (CORIXA CORP [US], et al) [X] 14-24,28-30 * page 2, line 25 - line 28 * * page 30, line 4 - page 32, line 5 * * claims 3,10 * * page 32, line 7 - page 34, line 29 *;
 [X]WO0204603  (EPPENDORF AG [DE], et al) [X] 14-21 * claims 19,20 *;
 [X]  - MORSE MICHAEL A ET AL, "Immunotherapy of cancer using dendritic cell", CYTOKINES CELLULAR AND MOLECULAR THERAPY, (199803), vol. 4, no. 1, ISSN 1368-4736, pages 35 - 44, XP009058112 [X] 14-24,28-30 * the whole document *
 [A]  - FOLCIK R M ET AL, "HIV-1 infection of placental cord blood monocyte-derived dendritic cells.", JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH. OCT 2001, (200110), vol. 10, no. 5, ISSN 1525-8165, pages 609 - 620, XP009058071

DOI:   http://dx.doi.org/10.1089/152581601753193823
International search[Y]  - PALUCKA A K ET AL, "Blood dendritic cells: Multi-potential differentiation or committed subsets?", BLOOD, (19991115), vol. 94, no. 10, page 48A, XP002903528
 [Y]  - GLUCKMAN J C ET AL, "In vitro generation of human dendritic cells and cell therapy", CYTOKINES. CELLULAR AND MOLECULAR THERAPHY, (1997), vol. 3, pages 187 - 196, XP000938414
 [Y]  - CHOI G S ET AL, "Analysis of Methods for the Generation of Dendritic Cells from Human Peripheral Blood Monocytes.", YONSEI MEDICAL JOURNAL, (2000), vol. 41, no. 5, pages 642 - 650, XP002903508
 [Y]  - FEUERSTEIN B ET AL, "A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use", JOURNAL OF IMMUNOLOGICAL METHODS, (2000), vol. 245, pages 15 - 29, XP004218805

DOI:   http://dx.doi.org/10.1016/S0022-1759(00)00269-6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.